Sun Pharmaceutical P/B Ratio
SUNPHARMA • Price-to-Book ratio analysis and book value breakdown
Current P/B Ratio
5.3
High Valuation
Very High - Significant premium, high growth expectations or speculative
Current Valuation Metrics
P/B Ratio
5.3
Current Price
₹1728.90
Book Value/Share
₹3020.25
Exchange
NSE
Book Value Breakdown (2025)
Balance Sheet Components
Total Equity
₹72,486 Cr
Share Capital
₹240 Cr
Reserves & Surplus
₹71,978 Cr
Outstanding Shares
240,000,000
Book Value per Share
₹3020.25
Valuation Signal
Signal
Overvalued
Historical Avg
0.53
Historical Range
0.41 - 0.67
Percentile
100.0%
Sector Context
Sector Average
-0.09
Sector Median
0.65
Sector Rank
#11 of 50
Sector Percentile
22.0%
Key P/B Ratio Insights for Sun Pharmaceutical
- Stock appears overvalued with PB of 5.3, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 907.6% above historical average
- Trading at premium to sector average PB of -0.09
View the current stock price of Sun Pharmaceutical for more insights.
P/B Ratio Historical Trend for Sun Pharmaceutical
Historical P/B ratio trend based on balance sheet data. P/B below 1.0 may indicate undervaluation, while higher ratios suggest growth expectations or asset-light business models.
Related Pages for Sun Pharmaceutical
Additional stock information and data for SUNPHARMA
Historical P/B Ratio Data
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 0.57 | ₹3020.25 | ₹1719.70 | ₹72,486 | Low |
| 2024 | 0.67 | ₹2796.92 | ₹1886.35 | ₹67,126 | Low |
| 2023 | 0.51 | ₹2471.5 | ₹1259.45 | ₹59,316 | Low |
| 2022 | 0.47 | ₹2127.75 | ₹1001.40 | ₹51,066 | Low |
| 2021 | 0.41 | ₹2061.67 | ₹845.70 | ₹49,480 | Low |
Sector P/B Ratio Comparison
Comparing Sun Pharmaceutical with other companies in Healthcare sector
Sector Average
-0.09
Sector Median
0.65
Lowest P/B
-12.71
Highest P/B
1.2
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sun Pharma Advanced Rese… | SPARC | -12.71 | ₹4,389 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.47 | ₹95 | Low |
| Parmax Pharma | PARMAX | -2.15 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.96 | ₹154 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |
| Murae Organisor | MURAE | 0.27 | ₹57 | Low |